850429-59-3 Usage
Uses
Used in Pharmaceutical Industry:
4-Bromo-1,2-dimethyl-1H-imidazole is used as an intermediate compound for the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the development of new drugs, particularly those targeting specific biological pathways or receptors.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Bromo-1,2-dimethyl-1H-imidazole is used as a building block for the creation of new agrochemicals. Its properties can be harnessed to develop compounds that are effective in controlling pests, diseases, and weeds in agricultural settings.
Used in Dye Industry:
4-Bromo-1,2-dimethyl-1H-imidazole is used as a chemical intermediate in the production of dyes. Its ability to form various chemical structures makes it a valuable component in the synthesis of dyes with specific color properties and stability.
Used in Research and Development:
4-Bromo-1,2-dimethyl-1H-imidazole is also used in research and development settings, where its unique chemical properties are explored for potential applications in various fields, including materials science, chemical engineering, and biotechnology. Its versatility as a compound makes it a valuable tool for scientists and researchers.
Check Digit Verification of cas no
The CAS Registry Mumber 850429-59-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,4,2 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 850429-59:
(8*8)+(7*5)+(6*0)+(5*4)+(4*2)+(3*9)+(2*5)+(1*9)=173
173 % 10 = 3
So 850429-59-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H7BrN2/c1-4-7-5(6)3-8(4)2/h3H,1-2H3
850429-59-3Relevant academic research and scientific papers
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
-
Paragraph 1069, (2020/10/09)
The invention relates to modulators of Embryonic Ectoderm Development (EED) and/or Polycomb Repressive Complex 2 (PRC2) useful in the treatment of disorders and diseases associated with EEC and PRC2, being macrocyclic azolopyridine derivatives and compositions thereof of Formula (I), or a pharmaceutically acceptable salt, prodrug, solvate, hydrate, enantiomer, isomer, or tautomer thereof, wherein X1, X2, X3, A1, A2, Y, R1, R2, R3, and R4 are as described herein.
5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS
-
Page/Page column 54, (2009/03/07)
The present invention relates to novel compounds that are CGRP receptor antagonists, processes for their preparation, to compositions containing them and to their use in the treatment of migraine, headache, and cluster headache.